Implementation of neoadjuvant immunotherapy in stage III melanoma: a modified Delphi consensus study in a European-accredited cancer center in Ireland
Our process identified important knowledge gaps regarding the multidisciplinary care of stage III melanoma. The statements generated will be used to develop a local pathway for the implementation of neoadjuvant immunotherapy in melanoma, with plans to further expand the Delphi process to other Irish institutions incorporating up to date published data to refine recommendations.
Authors
- Bryan T. Hennessy (ORCID: https://orcid.org/0000-0002-7871-6477)
- Aileen O’Shea (ORCID: https://orcid.org/0000-0002-2172-7087)
- Nazmy Elbeltagi
- Megan Greally (ORCID: https://orcid.org/0000-0001-9635-9541)
- Barry O’Sullivan (ORCID: https://orcid.org/0000-0002-0090-2085)
- Nadeem Ajmal
- Fiachra Martin
- Jarushka Naidoo (ORCID: https://orcid.org/0000-0002-3470-8686)
- Christopher Cronin (ORCID: https://orcid.org/0000-0002-2715-7273)
- Oscar S. Breathnach
- Patrick G. Morris (ORCID: https://orcid.org/0000-0002-6055-5273)
- James D Martin-Smith
- Christian Gulmann
- Muireann Roche
- Paul D. Sullivan
- Adrian Murphy
- Liam Grogan
Institutions
- Beaumont Hospital (IE)
- Dublin City University (IE)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1093/oncolo/oyaf265
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00